Conferences
ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
2018 ASCO Annual Meeting
1 - 5 Jun 2018
McCormick Place, Chicago, United States of America
ASCO 2018 conference round up
Dr Bishal Gyawali and Will Davies
24 Jun 2018
Repurposing selective PDE5 inhibitors as anti-cancer agents
Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium
5 Jun 2018
First results of DREAM trial of frontline durvalumab for mesothelioma
Prof Anna Nowak - The University of Western Australia, Perth, Australia
5 Jun 2018
Results from the phase I ICONIC trial
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
4 Jun 2018
Chemotherapy plus durvalumab in triple negative breast cancer
Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
4 Jun 2018
Phase II results of olaparib and abiraterone for mCRPC
Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK
4 Jun 2018
Global treatment pattern variations in HCC
Dr Nahum Mendez-Sanchez - Medica Sur Clinic and Foundation, Mexico City, Mexico
4 Jun 2018
Design and interim safety analysis of GeparX trial
Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
4 Jun 2018
Key developments in non-metastatic and metastatic hormone-sensitive prostate can...
Dr Eleni Efstathiou, Prof Nicholas Mottet, Dr Andrew Armstrong and Prof Maria De...
4 Jun 2018
International cancer control plans
Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana
4 Jun 2018
Economic impact of NGS in non small cell lung cancer
Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA
4 Jun 2018
Subcutaneous daratumumab shows benefit in patients with relapsed or refractory m...
Dr Ajai Chari - Mount Sinai Hospital, New York, USA
4 Jun 2018
Avelumab in combinations for lung cancer and update from ALEX study
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
4 Jun 2018
Updates in melanoma from ASCO 2018
Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
4 Jun 2018
Novel fusion proteins to target PD-L1 in HPV associated cancers
Dr James Gulley - Center for Cancer Research, Washington, USA
4 Jun 2018
Daratumumab in combination with carfilzomib and dexamethasone for relapsed multi...
Dr Ajai Chari - Mount Sinai Hospital, New York, USA
4 Jun 2018
Phase I study results of M7824 for patients with HPV associated cancers
Dr Julius Strauss - Center for Cancer Research, Washington, USA
4 Jun 2018
Phase III results of PROSPECT study for metastatic, castration-resistant prostat...
Dr James Gulley - Center for Cancer Research, Washington, USA
4 Jun 2018
Pancreatic survival improved with trial chemotherapy regimen after surgery
Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
4 Jun 2018
Aspirin combined with acid-reducing medicine offers moderate benefits in patient...
Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic o...
4 Jun 2018
Pre-operative chemotherapy with radiation may help people with pancreatic cancer...
Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands
4 Jun 2018
Heated abdominal chemotherapy not beneficial in patients with advanced colorecta...
Dr Francois Quenet - Regional Cancer Institute, Montpellier, France
4 Jun 2018
Comment: Pancreatic cancer survival extended by over a year with chemotherapy re...
Dr Andrew Epstein and Prof Richard Schilsky
4 Jun 2018
Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal cance...
Dr Andrew Epstein and Prof Richard Schilsky
4 Jun 2018
Comment: Improved 2 year survival for pancreatic cancer with pre-operative chemo...
Dr Andrew Epstein, Prof Richard Schilsky and Dr Geertjan van Tienhoven
4 Jun 2018
Comment: No benefit of heated abdominal chemotherapy in advanced colorectal canc...
Prof Richard Schilsky, Dr Andrew Epstein and Dr Francois Quenet
4 Jun 2018
Pancreatic cancer survival extended by over a year with chemotherapy regimen
Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
4 Jun 2018
Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high...
Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic o...
4 Jun 2018
Improved 2 year survival for pancreatic cancer with pre-operative chemoradiation
Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands
4 Jun 2018
No benefit of heated abdominal chemotherapy in advanced colorectal cancer
Dr Francois Quenet - Regional Cancer Institute, Montpellier, France
4 Jun 2018
Dabrafenib halts growth of low-grade paediatric glioma
Dr Mark Kieran - Dana Farber Cancer Institue, Boston, USA
4 Jun 2018
ASCO 2018: Novel treatment strategies in prostate cancer therapeutics
Prof Karim Fizazi and Dr Neal Shore
4 Jun 2018
ASCO 2018: Latest developments in non-metastatic and metastatic castration-resis...
Dr Neal Shore, Dr Simon Chowdhury, Prof Matthew Smith and Prof Boris Hadaschik
3 Jun 2018
Finding appropriate doses for HER2 positive breast cancers
Dr Mariana Chavez-MacGregor - MD Anderson Cancer Center, Houston, USA
3 Jun 2018
Updates in targeted therapy for melanoma
Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany
3 Jun 2018
Education, collaboration and communication in global cancer control
Dr Susannah Stanway - Royal Marsden NHS Foundation Trust, London, UK
3 Jun 2018
Health related quality of life findings from COMBI-AD
Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany
3 Jun 2018
Developing a survivin vaccine for glioblastoma
Dr Michael Ciesielski - Roswell Park Comprehensive Cancer Center, Buffalo, USA
3 Jun 2018
Early results from a 3rd gen EGFR-TKI in advanced NSCLC
Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea
3 Jun 2018
New pathways in pancreatic cancer
Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA
3 Jun 2018
OPTIMISMM trial for refractory multiple myeloma
Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA
3 Jun 2018
Treatment updates in Merkel cell carcinoma
Dr Paul Nghiem - University of Washington, Seattle, USA
3 Jun 2018
Results from the LILAC study of ABP 980 with trastuzumab for HER2 early breast ...
Dr Hans-Christian Kolberg - Marienhospital Bottrop, Bottrop, Germany
3 Jun 2018
New treatment markers for myeloma
Dr Jesus San Miguel - Universidad de Navarra, Pamplona, Spain
3 Jun 2018
Most breast cancer patients could avoid chemo with use of genetic testing
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
3 Jun 2018
Pembrolizumab works better than chemotherapy alone as initial treatment for NSCL...
Dr Gilberto Lopes - Sylvester Comprehensive Cancer Center, Miami, USA
3 Jun 2018
Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
3 Jun 2018
Sunitinib with or without surgery for metastatic renal cell carcinoma
Prof Arnaud Mejean - Paris Descartes University, Paris, France
3 Jun 2018
Comment: Genetic testing of early breast tumours could allow patients to go with...
Dr Harold Burstein & Prof Richard Schilsky
3 Jun 2018
Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer tr...
Dr John Heymach & Prof Richard Schilsky
3 Jun 2018
Comment: Paediatric rhabdomyosarcoma survival extended with maintenance chemothe...
Prof Richard Schilsky & Dr Gianni Bisogno
3 Jun 2018
Comment: Kidney surgery may be unneeded in many intermediate-risk patients
Dr Sumanta Pal & Prof Richard Schilsky
3 Jun 2018
Genetic testing of early breast tumours could allow patients to go without chemo
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
3 Jun 2018
PD-1 immunotherapy better than chemo alone as first line lung cancer treatment
Dr Gilberto Lopes - Oncoclinicas do Brasil, São Paulo, Brazil
3 Jun 2018
Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
3 Jun 2018
Kidney surgery may be unneeded in many intermediate-risk patients
Prof Arnaud Mejean - Paris Descartes University, Paris, France
3 Jun 2018
ASCO 2018: Latest in bladder cancer treatments
Prof Thomas Powles & Prof Shahrokh Shariat
3 Jun 2018
Cancer treatment in the last 6 months of life: when inaction can outperform acti...
Dr Bishal Gyawali - Brigham and Women's Hospital, Boston, USA
3 Jun 2018
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer
Prof Kurt Miller and Prof Bertrand Tombal
2 Jun 2018
A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER...
Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA
2 Jun 2018
Zoptarelin no better than doxarubicin for second-line advanced endometrial cance...
Dr David Miller - The University of Texas Southwestern Medical Center
2 Jun 2018
Improving global breast cancer care
Prof Carlos Barrios - Pontifica Universidade Catolica de Rio Grande do Sul, Braz...
2 Jun 2018
What will we expect from novel therapies for oesophageal and gastric malignancie...
Prof Ramon De Mello - University of Algarve, Faro, Portugal
2 Jun 2018
Nelarabine in newly diagnosed paediatric T-cell malignancies
Dr Kimberly Dunsmore - University of Virginia School of Medicine, Virginia, USA
2 Jun 2018
Immunotherapy trials and hyperprogressive disease
Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
2 Jun 2018
First-in-human phase 1 study of TAK-931 for solid tumours
Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan
2 Jun 2018
Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in...
Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France
2 Jun 2018
The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CL...
Prof William Wierda - MD Anderson Cancer Center, Houston, USA
2 Jun 2018
Development of blood tests for early lung cancer
Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA
2 Jun 2018
Linking Lynch Syndrome and microsatellite instability in tumours
Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA
2 Jun 2018
Matching personalised therapies to patients in the IMPACT trial
Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA
2 Jun 2018
Atezolizumab with chemotherapy improves PFS in squamous NSCLC
Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA
2 Jun 2018
Matching mutations in tumours to precision medicine improves survival
Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA
2 Jun 2018
Development of blood tests for early lung cancer
Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA
2 Jun 2018
Genomic study links several new cancers to Lynch Syndrome
Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA
2 Jun 2018
Taselisib with fulvestrant slows growth of advanced breast cancer
Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA
2 Jun 2018
Atezolizumab with chemotherapy improves PFS in squamous NSCLC
Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA
2 Jun 2018
